XML 23 R13.htm IDEA: XBRL DOCUMENT v3.4.0.3
Warrants
3 Months Ended
Mar. 31, 2016
Equity [Abstract]  
Warrants

8.

Warrants

In connection with the Hercules Term Loan (see Note 5, Debt), the Company issued a warrant to purchase 128,231 shares of Series C convertible preferred stock. The convertible preferred stock warrant was recorded as a liability and is adjusted to fair value at each balance sheet date, with the change in fair value being recorded as a component of other income (expense), net in the condensed consolidated statements of operations. Upon issuance, the fair value of the warrant was estimated to be $158 thousand.  The Company recorded a gain of $66 thousand related to the change in fair value of preferred stock warrant liability as part of other income (expense), net in the accompanying condensed consolidated statements of operations for the three months ended March 31, 2015.  

The Company used Black-Scholes option-pricing model to estimate the fair value of the convertible preferred stock with the following assumptions:

 

 

March 31,

2015

 

Series C Warrant:

 

 

 

 

Expected term (in years)

 

0.5 – 1.2

 

Expected volatility

 

 

25.0%

 

Risk-free interest rate

 

0.3% – 0.6%

 

Expected dividend yield

 

 

0%

 

Upon the closing of the Merger on July 23, 2015, all shares of Series C convertible preferred stock were converted into common stock, and the warrant to purchase Series C convertible preferred stock was converted into the warrant to purchase 128,231 shares of the Company’s common stock.  As a result, the fair value of the preferred stock warrant liability of $93 thousand was reclassified into additional paid-in capital.  At March 31, 2016 and December 31, 2015, the warrant had not been exercised and was still outstanding.

In connection with the Merger and the Private Placement, in July and August 2015, the Company issued warrants to purchase 198,760 shares of common stock at an exercise price of $5.00 per share to private placement agents as payment for services provided. These placement warrants are exercisable at any time at the option of the holder until the five year anniversary of its date of issuance.

The Company estimated the aggregate fair value of the placement warrants on the issuance date to be $316 thousand which was recorded in additional paid-in-capital as an offering cost against the total proceeds from the Private Placement.  The placement warrants were accounted for as equity awards.  At March 31, 2016 and December 31, 2015, the placement warrants had not been exercised and were still outstanding.  

 

The fair value of the placement warrants were valued at their grant dates using the Black-Scholes pricing model and the following weighted-average assumptions:

 

 

 

Upon Issuance

 

Preferred Stock Warrant:

 

 

 

 

Expected term (in years)

 

 

5.0

 

Expected volatility

 

 

31.8%

 

Risk-free interest rate

 

 

1.6%

 

Expected dividend yield

 

 

0%